Cargando…

When is the Best Time for the Second Antiplatelet Agent in Non-St Elevation Acute Coronary Syndrome?

Dual antiplatelet therapy is a well-established treatment in patients with non-ST elevation acute coronary syndrome (NSTE-ACS), with class I of recommendation (level of evidence A) in current national and international guidelines. Nonetheless, these guidelines are not precise or consensual regarding...

Descripción completa

Detalles Bibliográficos
Autores principales:	Silva, Pedro Gabriel Melo de Barros e, Ribeiro, Henrique Barbosa, Baruzzi, Antônio Claudio do Amaral, da Silva, Expedito Eustáquio Ribeiro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Sociedade Brasileira de Cardiologia - SBC 2016
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4811279/ https://www.ncbi.nlm.nih.gov/pubmed/27027367 http://dx.doi.org/10.5935/abc.20160042

Ejemplares similares

Risks and Benefits of Thrombolytic, Antiplatelet, and Anticoagulant Therapies for ST Segment Elevation Myocardial Infarction: Systematic Review
por: Nascimento, Bruno Ramos, et al.
Publicado: (2014)

Geoprivacy in Neighbourhoods and Health Research: A Mini-Review of the Challenges and Best Practices in Epidemiological Studies
por: Ribeiro, Ana Isabel, et al.
Publicado: (2022)

Safety of Antiplatelet Pretreatment in Non-ST-segment Elevation Acute Coronary Syndrome
por: Torres-Ruiz, G, et al.
Publicado: (2023)

When Second Best Might Be the Best: Using Hospitalization Data to Monitor the Novel Coronavirus Pandemic
por: Mallow, Peter J., et al.
Publicado: (2020)

Management of ST-elevation myocardial infarction in the setting of anterior epistaxis: focused on antiplatelet and antithrombotic therapies
por: Handoyo, Victoria, et al.
Publicado: (2019)

Variation in Practice Regarding Pretreatment With Dual Antiplatelet Therapy for Patients With Non–ST Elevation Myocardial Infarction
por: Shafiq, Ali, et al.
Publicado: (2016)

Comparison of bioavailability and antiplatelet action of ticagrelor in patients with ST-elevation myocardial infarction and non-ST-elevation myocardial infarction: A prospective, observational, single-centre study
por: Adamski, Piotr, et al.
Publicado: (2017)

The dogma of aspirin: a critical review of evidence on the best monotherapy after dual antiplatelet therapy
por: Polo Friz, Hernan, et al.
Publicado: (2015)

Acute ST-elevation Myocardial Infarction after Upper Gastrointestinal Bleeding: A Clinical Dilemma of Antiplatelet Therapy
por: Xue, Wen-Qiang, et al.
Publicado: (2018)

Spinal cord hemorrhage: a rare complication of dual antiplatelet therapy for non-ST elevation myocardial infarction
por: Yu, Xing, et al.
Publicado: (2019)

Ticagrelor or clopidogrel dual antiplatelet therapy following a pharmacoinvasive strategy in ST‐segment elevation myocardial infarction
por: Welsh, Robert C., et al.
Publicado: (2021)

ST-Segment Elevation: An Unexpected Culprit
por: Sá Couto, David, et al.
Publicado: (2023)

Improving quality indicators for the treatment of acute myocardial infarction: impact of the disease-specific care certification
por: Melo de Barros e Silva, PG, et al.
Publicado: (2013)

A Pleasant Surprise in the Face of ST-Segment Elevation
por: Sousa-Nunes, Fábio, et al.
Publicado: (2021)

A Coronary Artery Anomaly Presenting as Acute Coronary Syndrome: A Case Report
por: de A. Chaud, Mariana S., et al.
Publicado: (2021)

Evaluation of the Society of Thoracic Surgeons score system for isolated coronary bypass graft surgery in a Brazilian population
por: Ikeoka, Dimas Tadahiro, et al.
Publicado: (2014)

Best Fit Sphere Back and Adjusted Maximum Elevation of Corneal Back Surface as Novel Predictors of Keratoconus Progression
por: Ribeiro, Margarida, et al.
Publicado: (2022)

Genotype- and Phenotype-Directed Personalization of Antiplatelet Treatment in Patients with Non-ST Elevation Acute Coronary Syndromes Undergoing Coronary Stenting
por: Ahn, Sung Gyun, et al.
Publicado: (2013)

Pulmonary alveolar hemorrhage mimicking a pneumopathy: a rare complication of dual antiplatelet therapy for ST elevation myocardial infarction
por: Oualim, Sara, et al.
Publicado: (2016)

Invasive and antiplatelet treatment of patients with non‐ST‐segment elevation myocardial infarction: Understanding and addressing the global risk‐treatment paradox
por: Ahrens, Ingo, et al.
Publicado: (2019)

MiR-223 or miR-126 predicts resistance to dual antiplatelet therapy in patients with ST-elevation myocardial infarction
por: Li, Xiaojing, et al.
Publicado: (2021)

Risk of Heart Failure in Patients with ST-Elevation Myocardial Infarction Receiving Drug-Eluting Stent Implantation and Undefined Duration of Antiplatelets
por: Chien, Li-Nien, et al.
Publicado: (2022)

Settling for second best: when should doctors agree to parental demands for suboptimal medical treatment?
por: Nair, Tara, et al.
Publicado: (2017)

Factors associated with longer delays in reperfusion in ST-segment elevation myocardial infarction
por: Abreu, Daisy, et al.
Publicado: (2014)

Improving Indicators in a Brazilian Hospital Through Quality-Improvement Programs Based on STS Database Reports
por: Silva, Pedro Gabriel Melo de Barros e, et al.
Publicado: (2015)

Non–ST‐Segment–Elevation Myocardial Infarction: When Is Rapid Revascularization Critical?
por: Case, Brian C., et al.
Publicado: (2021)

Prolonged dual antiplatelet therapy in patients with non‐ST‐segment elevation myocardial infarction: 2‐year findings from EPICOR Asia
por: Zou, Yanan, et al.
Publicado: (2020)

Effectiveness of dual antiplatelet de-escalation therapy on the prognosis of patients with ST segment elevation myocardial infarction undergoing percutaneous coronary intervention
por: Zhao, Zhigang, et al.
Publicado: (2023)

Real World of Percutaneous Coronary Interventions in the Public Health System in Rio de Janeiro: How Can It Be Improved?
por: Garzon, Stefano, et al.
Publicado: (2018)

When local isn't best
por: Jones, Thomas A
Publicado: (2013)

Implementation of an institutional protocol for rational use of blood products and its impact on postoperative cardiac surgery
por: de Barros e Silva, PGM, et al.
Publicado: (2013)

Analysis of the Best Timing for Applying Tirofiban in PCI Operation for the Patients with ST Segment Elevation Myocardial Infarction
por: Lei, Zhang, et al.
Publicado: (2015)

BaltDC: purification, characterization and infrared spectroscopy of an antiplatelet DC protein isolated from Bothrops alternatus snake venom
por: Matias, Mariana Santos, et al.
Publicado: (2017)

Implementation of an institutional protocol for rational use of blood products and its impact on postoperative of coronary artery bypass graft surgery
por: Silva, Pedro Gabriel Melo de Barros e, et al.
Publicado: (2013)

Bivalirudin plus loading dose of cilostazol-based triple-antiplatelet in treatment of non-ST-elevation myocardial infarction following percutaneous coronary intervention
por: Wang, Mei, et al.
Publicado: (2015)

Metabolic Disturbances Identified in Plasma Samples from ST-Segment Elevation Myocardial Infarction Patients
por: Goulart, Vânia Aparecida Mendes, et al.
Publicado: (2019)

Predictors of in-hospital mortality in patients with ST-segment elevation myocardial infarction undergoing pharmacoinvasive treatment
por: de Andrade Falcão, Felipe José, et al.
Publicado: (2013)

When the Best Pandemic Models are the Simplest
por: Jahedi, Sana, et al.
Publicado: (2020)

The Impact of Patient Characteristics and Antiplatelet Regimes on Clot Microstructure in Patients Treated for ST Elevation Myocardial Infarction: Clot Microstructure can Evaluate Therapeutic Efficacy
por: Lawrence, Matthew J., et al.
Publicado: (2023)

When the bomb is inside the heart: atrial myxoma presenting as ST-segment elevation myocardial infarction
por: Fernández de-Aspe, Pablo, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_r4bj1s59dkbe0n2rdptgk79igu